Information Library
Connect with investigators, regulators and physicians
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
ASCO 2010 Annual Meeting
June 4 - June 8, 2010
Exhibit Dates: June 5 - 7, 2010 Exhibitor Booth Number: 2053 -
Diagnosing an Underperforming Drug
August 19, 2009
Learn how Eidetics uncovered barriers to market success for a customer’s new product launch and delivered insights to optimize marketing and sales strategies. -
Services for Biotechnology
July 20, 2009
We Understand the Dynamic Needs of Biotech -
For Investigators: Public Perception
July 17, 2009
Find out more about the public perception of clinical trials. -
For Investigator: Patient Relationships
July 17, 2009
Understand patient relationship management. -
For Investigors: Market Situation
July 17, 2009
Learn about the clinical trial market situation. -
Incremental Cost of Otitis Media Among Children in the United States
June 25, 2009
Using a nationally representative data source, the study estimates the medical cost of treating otitis media among children in the US. The costs are estimated at $2 billion in 2005. -
Patient Registries: A Taxonomy for the Design, Development and Implementation
June 25, 2009
Recommendations from the ISPOR Patient Registry Classification, Strategy & Design Working Group, Team 2, for developing standard language for the characterization, classification, strategy, design, and execution of patient registries to generate data for outcomes research purposes. -
Medicare Part D’s Effect On Prescribing Volume
June 25, 2009
Poster presented during the ISPOR 14th Annual International Meeting 2009 (International Society for Pharmacoeconomics and Outcomes Research) titled “Medicare Part D’s Effect On Prescribing Volume: Average Monthly Utilization of Selected High Use Drugs In The Six Protected Classes, By Different Specialties.” -
Diabetes Proactive Proposal
June 24, 2009
New FDA Guidances On Anti-Diabetes Therapies Change the Landscape of Drug Development. How Quintiles Can Help You Navigate the Guidances and Successfully Develop Pipeline Drug Candidates.